India, Sept. 25 -- This company belongs to the group of diagnostic services companies in India offering pathology, clinical laboratory, and diagnostic test services through their laboratories and sampling centers.

The shares of Dr Lal PathLabs are currently trading at Rs. 1937.80, down by 1.24%. The company has a market capitalization of RS. 32,443.50 crore. The stock's 52 week high is Rs. 2,035.00 and its 52 week low is Rs. 1,272.00. In the past 6 months the stock has delivered a return of 43.83%.

What's The News Approvals have been received from Dr Lal PathLabs Limited for acquisition of 70% equity shares in SN Genelab Private Limited (SN Gene). This transaction has been approved by the company's Board of Directors on September 24, 2...